Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

SPRYSPRY
Showing 8 of 17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ARS PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 380,770 shares of SPRY (ARS PHARMACEUTICALS INC), worth $3M as of 2026-Q2. The position was decreased (-47.4% shares). SPRY represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$3M

Current Shares

380,770

Total Value Change

-$949,931

Total Shares Change

+104,915

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
380,770
-47.4%
$3M0.0%$8.01
0
2026-Q1
Decreased
724,219
-10.8%
$5.8M0.0%$8.87
0
2025-Q4
Decreased
812,036
-38.8%
$9.5M0.0%$11.64
0
2025-Q3
Decreased
1.3M
-9.5%
$13.3M0.0%$9.72
0
2025-Q2
Increased
1.5M
+104.0%
$25.6M0.0%$18.20
46
2025-Q1
Decreased
717,953
-19.0%
$9M0.0%$12.49
0
2024-Q4
Increased
886,117
+221.2%
$9.3M0.0%$10.62
45
2024-Q3
Decreased
275,855
-37.4%
$4M0.0%$14.32
0

Other major holders of SPRY: FMR LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used